Nashville-based InvisionHeart, a cardiac data technology company, has raised $1.9 million in Series A financing led by The Martin Companies.
InvisionHeart is based on wireless electrocardiogram technology developed at Vanderbilt University and aims to capture and analyze cardiac data through mobile hardware and cloud-based transmission. Its growth capital, which also came from TriStar Technology Ventures, Mountain Group Capital and NueCura Partners, will help complete its technology buildout, seek clearance from the U.S. Food and Drug Administration and begin pilot sales. The electrocardiogram is part of a larger communication system that includes smartphones, tablets and a HIPAA-compliant platform.
"We are very pleased to have brought together such a seasoned group of investors," Dr. Josh Nickols, CEO of InvisionHeart, said in a release. "Their collective experience will be invaluable as we move InvisionHeart forward."
Additionally, David Landman has been named COO and Christopher Rand will serve as chairman of the board of directors. Landman is a former president of tech transfer company Vertex Clinical Innovations while Rand is a co-founder and partner at TriStar Technology Ventures.
"A critical component of the ACA is making sure patients receive appropriate care in the appropriate setting," said Charlie Martin, founder of The Martin Companies. "The technology under development at InvisionHeart does just that by allowing clinicians to remotely analyze critical patient data. This gives patients access to top notch expertise in lower cost settings, like ambulatory care facilities, while reducing cost."